Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and Activated Collagen in Total Joint Arthroplasty
NCT03158623Phase 3Completed
- Sponsor
- Salt Lake Orthopedic Clinic
- Start
- Apr 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Adoptive Cell Transfer
01
Overview
Phase 3, randomised trial of autologous platelet-rich plasma and CellerateRX in surgical wound (3 arms), sponsored by Salt Lake Orthopedic Clinic. Primary endpoint: Wound Status at 6 weeks. Started Apr 2016; status: completed.
02
Drugs
autologous platelet-rich plasmaCellerateRX
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT03158623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158623.